Yubing Zhou Selected Research

Yubing Zhou Research Topics

Disease

17	Neoplasms (Cancer) 04/2024 - 04/2005
6	Breast Neoplasms (Breast Cancer) 12/2023 - 05/2015
4	Carcinogenesis 04/2024 - 05/2015
3	Esophageal Squamous Cell Carcinoma 04/2024 - 01/2023
3	Osteosarcoma (Osteogenic Sarcoma) 01/2024 - 06/2016
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 03/2019
2	Infections 11/2018 - 01/2012
2	Neoplasm Metastasis (Metastasis) 08/2018 - 06/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2016 - 01/2015
2	Hyperammonemia 05/2015 - 08/2014
2	Acute Promyelocytic Leukemia 04/2010 - 04/2005
2	Leukemia 04/2005 - 09/2000
1	Type 2 Diabetes Mellitus (MODY) 03/2024
1	Lung Neoplasms (Lung Cancer) 05/2021
1	Inflammation (Inflammations) 05/2021
1	Acute Lung Injury 05/2021
1	Chondrosarcoma 04/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Persistent Infection 11/2018
1	Ovarian Epithelial Carcinoma 10/2017
1	Stomach Neoplasms (Stomach Cancer) 05/2016
1	Retinoblastoma (Glioblastoma, Retinal) 01/2015
1	Liver Failure 08/2014
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2011
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2000
1	Myeloid Leukemia (Leukemia, Myelocytic) 09/2000
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2000

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 04/2024 - 05/2015
3	Small Interfering RNA (siRNA)IBA 05/2018 - 05/2015
2	6-methyladenineIBA 04/2024 - 01/2021
2	MicroRNAs (MicroRNA)IBA 01/2024 - 08/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024 - 12/2023
2	RNA (Ribonucleic Acid)IBA 01/2020 - 08/2018
2	Antiviral Agents (Antivirals)IBA 11/2018 - 01/2012
2	Lamivudine (Epivir)FDA Link 11/2018 - 01/2012
2	palbociclibIBA 05/2018 - 06/2016
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 06/2016 - 05/2015
2	Messenger RNA (mRNA)IBA 01/2016 - 05/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 09/2000
2	AmmoniaIBA 05/2015 - 08/2014
2	AntigensIBA 01/2011 - 04/2005
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2011 - 04/2005
1	Leucine (L-Leucine)FDA Link 04/2024
1	OxidesIBA 04/2024
1	ChemokinesIBA 04/2024
1	Immune Checkpoint InhibitorsIBA 04/2024
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2024
1	Antineoplastic Agents (Antineoplastics)IBA 03/2024
1	Metformin (Glucophage)FDA LinkGeneric 03/2024
1	Benzydamine (Tantum)IBA 04/2023
1	Pizotyline (BC 105)IBA 01/2023
1	malic acid (malate)IBA 01/2023
1	AntioxidantsIBA 01/2023
1	Leukocyte Elastase (Neutrophil Elastase)IBA 05/2021
1	SolventsIBA 04/2021
1	EnzymesIBA 01/2021
1	alpha-hydroxyglutarateIBA 01/2021
1	N-methyladenosineIBA 01/2021
1	keishibukuryoganIBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020
1	TensinsIBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	Oxygen (Dioxygen)IBA 03/2019
1	Pyruvic Acid (Pyruvate)IBA 03/2019
1	Oxidoreductases (Dehydrogenase)IBA 03/2019
1	LuciferasesIBA 08/2018
1	Cyclin-Dependent Kinase 4IBA 05/2018
1	CateninsIBA 10/2017
1	MatrinesIBA 11/2016
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 06/2016
1	3-deazaneplanocinIBA 06/2016
1	Type 4 Fibroblast Growth Factor ReceptorIBA 05/2016
1	Fluorouracil (Carac)FDA LinkGeneric 05/2016
1	PD 173074IBA 05/2016
1	CyclinsIBA 05/2015
1	Urea (Carbamide)FDA LinkGeneric 05/2015
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2015
1	BilirubinIBA 08/2014
1	cepharanthineIBA 01/2014
1	A-Form DNA (A-DNA)IBA 04/2010
1	VaccinesIBA 04/2010

Therapy/Procedure

5	Therapeutics 04/2024 - 06/2016
3	Drug Therapy (Chemotherapy) 01/2024 - 06/2016
1	Immunotherapy 01/2021